(Q42691780)

4 November 2017

title

Risperidone in chronic schizophrenia: a detailed audit, open switch study and two-year follow-up of patients on depot medication (English)

1 reference

4 November 2017

1 reference

chronic schizophrenia

1 reference

1 reference

Conlon L

1

1 reference

4 November 2017

Fahy TJ

2

1 reference

4 November 2017

OToole R

3

1 reference

4 November 2017

Gilligan J

4

1 reference

4 November 2017

Prescott P

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

4 November 2017

1 reference

4 November 2017

volume

17

1 reference

4 November 2017

issue

8

1 reference

4 November 2017

page(s)

459-465

1 reference

A rating scale for drug-induced akathisia

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Insight and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Fortnightly review. Treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Observations on switching patients with schizophrenia to risperidone treatment. Risperidone Switching Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Compliance therapy in psychotic patients: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Self-report quality of life measure for people with schizophrenia: the SQLS

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

A depression rating scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

A survey of the attitudes of chronic psychiatric patients living in the community toward their medication

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

Systematic review of patient and nurse attitudes to depot antipsychotic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900709-5

7 January 2021

10.1016/S0924-9338(02)00709-5

Identifiers

DOI

1 reference

4 November 2017

1 reference